Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products ...
John F. Kennedy’s granddaughter has disclosed that she has terminal cancer, writing in an essay in “The New Yorker” on ...
Why are vaccines so hard to make? The fda approved two mRNA vaccines for COVID-19, but it was a challenge to make this type ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...
Pfizer's mRNA flu vaccine posts promising NEJM results. Dr. Todd Ellerin of South Shore Health discusses safety, side effects ...
Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.
Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...
Scientists are increasingly looking at mRNA vaccines for cancer, not just viruses. The results of a study published in the journal Nature in October showed the promise of mRNA vaccines in fighting ...
Dr. David Gortler is a pharmacologist, pharmacist, and senior fellow in public health policy and regulation with the Center for Health and Welfare Policy at The Heritage Foundation. He is a former ...
A pharmacist holds a Pfizer and BioNTech COVID-19 vaccine shot on Thursday, April 24, 2025, in Portland, Ore. University of Florida researchers found that advanced lung and skin cancer patients lived ...
WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results